FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Jun 30, 2014
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on June 30, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- June 30, 2014
- Product Type
- Biologics
View Company Profile
ID · bacbf162-10ef-4032-8aca-926b7e4c99ff
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 887635
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 11, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 23, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1059959 - 2018-05-11
- FDA Inspection 796542 - 2012-07-11
- FDA Inspection 766276 - 2012-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.